Chemiluminescence Immunoassay Market worth $19.0 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271 Browse in-depth TOC on "Chemiluminescence Immunoassay Market" 181 - Tables 52 - Figures 283 - Pages Chemiluminescence Immunoassay Market Scope: In 2022, the consumables segment held the largest share of the chemiluminescence market, by product segment Based on...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271

Browse in-depth TOC on "Chemiluminescence Immunoassay Market"

181 - Tables
52 - Figures
283 - Pages

Chemiluminescence Immunoassay Market Scope:

In 2022, the consumables segment held the largest share of the chemiluminescence market, by product segment

Based on product, the global chemiluminescence immunoassay market is categorized into consumables and instruments. The repetitive purchase of consumables such as reagents for every test is a major factor driving the growth of the segment. Besides the availability of efficient assays and reagents for diagnostic purposes has propelled its demand among end users.

In 2022, the infectious disease diagnostics segment held the largest share of the chemiluminescence market, by application segment

The chemiluminescence immunoassay market, by application, has been segmented into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, gastroenterology, neurology, respiratory, therapeutic drug monitoring, metabolic disorders, and other applications. The large share of this segment can be attributed to the development and introduction of advanced assays for the diagnosis of different diseases & conditions, and the increase in the population with infectious diseases.

North America dominates the global chemiluminescence immunoassay market

Based on the region, the chemiluminescence immunoassay market is segmented into North America, Europe, Asia Pacific, and Rest of the world. In 2022, North America accounted for the largest share of the chemiluminescence immunoassay market. The large share of North America in this market can be attributed to the increasing prevalence of infectious diseases and cancer and rising healthcare spending, which is highly developed in the US and Canada.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=131865271

Chemiluminescence Immunoassay Market Dynamics:

Drivers:

1.  Rising incidence of chronic and infectious diseases across the globe

Restraints:

1.  High cost of CLIA related products

Opportunities:

1.  Increasing number of collaborations and partnerships in the CLIA market

Challenges:

1.  Lack of skilled professionals and aging workforce

Key Market Players:

Chemiluminescence Immunoassay Market worth $19.0 billion | MarketsandMarkets

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (US), Shenzhen Mindray Bio-medical Electronics Co., Ltd. (China), Sysmex Corporation (Japan), Diatron (Hungary), Getein Biotech, Inc. (China), Werfen (Spain), QuidelOrtho Corporation (US), EUROIMMUN (Germany), Merck KGaA (Germany), Tosoh Corporation (Japan), Trivitron Healthcare (India), Abnova Corporation (Taiwan), Elabscience (US), Maccura Biotechnology Co., Ltd. (China), Autobio Diagnostics Co., Ltd. (China), Jiangsu Zecen Biotech Co., Ltd (China), Rayto Life and Analytical Sciences Co., Ltd. (China), Daan Gene Co., Ltd. (China), DYNEX TECHNOLOGIES, Inc. (US), Zybio, Inc. (China), Wiener Laboratorios SAIC (Argentina), Tianjin Era Biology Technology Co., Ltd. (China).

Recent Developments:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=131865271

Chemiluminescence Immunoassay Market Advantages:

Overall, the advantages of the chemiluminescence immunoassay market lie in its sensitivity, specificity, wide analyte range, multiplexing capabilities, speed, automation, stability, point-of-care applications, clinical significance, and impact on research. These advantages position chemiluminescence immunoassays as a prominent technology in diagnostics and research, with the potential to revolutionize healthcare and scientific understanding in the coming years.

High-Throughput Screening Market - Report Objectives:

Related Reports:

CRISPR Market - Global Forecasts to 2028

Synthetic Biology Market - Global Forecasts to 2027

Glycomics / Glycobiology Market- Global Forecasts to 2027

Epigenetics Market - Global Forecasts to 2027

Laboratory Freezers Market - Global Forecasts to 2026

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/chemiluminescence-immunoassay-clia-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/chemiluminescence-immunoassay-clia.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/chemiluminescence-immunoassay-market-worth-19-0-billion--marketsandmarkets-301870058.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;